GlassScriptPhysician profile
Jayantibh M Patel
NPI 1366444341
$979.57
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $117 · 2021: $39.69 · 2022: $334 · 2023: $8.91 · 2024: $50.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $50.16 · Education: $8.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $50.16 |
| Education | $8.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $148.04 | 2019 | |
| Neurocrine Biosciences, INC. | $102.43 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $90.51 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $77.63 | 2022 | |
| Amgen INC. | $61.29 | 2019-2020 | |
| Microtransponder, INC. | $50.16 | 2024 | |
| Acadia Pharmaceuticals INC | $49.20 | 2020-2022 | |
| Acorda Therapeutics, INC | $42.17 | 2020 | |
| Ucb, INC. | $35.63 | 2019 | |
| Biogen, INC. | $34.18 | 2019-2020 | |
| Sk Life Science, INC. | $32.17 | 2022 | |
| Argenx US, INC. | $27.59 | 2022 | |
| Travere Therapeutics, INC. | $25.50 | 2022-2023 | Cholbam |
| Ge Healthcare | $25.20 | 2019 | |
| Celgene Corporation | $24.80 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otto Bock Healthcare LP | $22.11 | 2022 | |
| Jazz Pharmaceuticals INC. | $20.69 | 2022 | |
| Neurelis, INC. | $19.53 | 2022 | |
| Allergan, INC. | $18.51 | 2020 | |
| Abbvie INC. | $15.59 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $15.19 | 2019 | |
| Livanova USA, INC. | $15.11 | 2019 | |
| Neuropace, INC. | $15.08 | 2019 | |
| Supernus Pharmaceuticals, INC. | $11.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayantibh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.